RGEN FY 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$141M+35.1% YoY

Gross Profit

$74M52.5% margin

Operating Income

$14M9.9% margin

Net Income

$28M20.1% margin

EPS (Diluted)

$0.72

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$12M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$120M

Total Liabilities

$152M

Stockholders' Equity

$592M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$105M	+35.1%
Gross Profit	$74M	$57M	+29.2%
Operating Income	$14M	$16M	-12.3%
Net Income	$28M	$12M	+142.7%